The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Women Health Diagnostics Market Research Report 2025
Synopsis
Women are more prone to certain diseases, mostly related to menstrual disorders, depression, osteoporosis, obesity, and autoimmune diseases. Women's major health issues are related to the reproductive system that includes infertility, polycystic ovarian syndrome, menopause, and cancers such as breast cancer, cervical cancer, and urological disorders. This report analzyed the womens health diagnostics product.
The global Women Health Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Women Health Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women Health Diagnostics.
Report Scope
The Women Health Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Women Health Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women Health Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies, Inc.
Ariosa Diagnostics, Inc
Bio-Rad Laboratories, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Natera, Inc
PerkinElmer, Inc
Sequenom, Inc
LifeCodexx
Cenata
Berrygenomics
BGI
Segment by Type
Prenatal Testing
Down Syndrome
HPV
Fertility Test
Pregnancy Test
Other
Segment by Application
Hospitals
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Women Health Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Women are more prone to certain diseases, mostly related to menstrual disorders, depression, osteoporosis, obesity, and autoimmune diseases. Women's major health issues are related to the reproductive system that includes infertility, polycystic ovarian syndrome, menopause, and cancers such as breast cancer, cervical cancer, and urological disorders. This report analzyed the womens health diagnostics product.
The global Women Health Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Women Health Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women Health Diagnostics.
Report Scope
The Women Health Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Women Health Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women Health Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies, Inc.
Ariosa Diagnostics, Inc
Bio-Rad Laboratories, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Natera, Inc
PerkinElmer, Inc
Sequenom, Inc
LifeCodexx
Cenata
Berrygenomics
BGI
Segment by Type
Prenatal Testing
Down Syndrome
HPV
Fertility Test
Pregnancy Test
Other
Segment by Application
Hospitals
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Women Health Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women Health Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prenatal Testing
1.2.3 Down Syndrome
1.2.4 HPV
1.2.5 Fertility Test
1.2.6 Pregnancy Test
1.2.7 Other
1.3 Market by Application
1.3.1 Global Women Health Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Women Health Diagnostics Market Perspective (2019-2030)
2.2 Women Health Diagnostics Growth Trends by Region
2.2.1 Global Women Health Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Women Health Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Women Health Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Women Health Diagnostics Market Dynamics
2.3.1 Women Health Diagnostics Industry Trends
2.3.2 Women Health Diagnostics Market Drivers
2.3.3 Women Health Diagnostics Market Challenges
2.3.4 Women Health Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Women Health Diagnostics Players by Revenue
3.1.1 Global Top Women Health Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Women Health Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Women Health Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Women Health Diagnostics Revenue
3.4 Global Women Health Diagnostics Market Concentration Ratio
3.4.1 Global Women Health Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women Health Diagnostics Revenue in 2023
3.5 Women Health Diagnostics Key Players Head office and Area Served
3.6 Key Players Women Health Diagnostics Product Solution and Service
3.7 Date of Enter into Women Health Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Women Health Diagnostics Breakdown Data by Type
4.1 Global Women Health Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Women Health Diagnostics Forecasted Market Size by Type (2025-2030)
5 Women Health Diagnostics Breakdown Data by Application
5.1 Global Women Health Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Women Health Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Women Health Diagnostics Market Size (2019-2030)
6.2 North America Women Health Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Women Health Diagnostics Market Size by Country (2019-2024)
6.4 North America Women Health Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Women Health Diagnostics Market Size (2019-2030)
7.2 Europe Women Health Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Women Health Diagnostics Market Size by Country (2019-2024)
7.4 Europe Women Health Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Women Health Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Women Health Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Women Health Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Women Health Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Women Health Diagnostics Market Size (2019-2030)
9.2 Latin America Women Health Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Women Health Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Women Health Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Women Health Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Women Health Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Women Health Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Women Health Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Detail
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Women Health Diagnostics Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Women Health Diagnostics Business (2019-2024)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Ariosa Diagnostics, Inc
11.2.1 Ariosa Diagnostics, Inc Company Detail
11.2.2 Ariosa Diagnostics, Inc Business Overview
11.2.3 Ariosa Diagnostics, Inc Women Health Diagnostics Introduction
11.2.4 Ariosa Diagnostics, Inc Revenue in Women Health Diagnostics Business (2019-2024)
11.2.5 Ariosa Diagnostics, Inc Recent Development
11.3 Bio-Rad Laboratories, Inc
11.3.1 Bio-Rad Laboratories, Inc Company Detail
11.3.2 Bio-Rad Laboratories, Inc Business Overview
11.3.3 Bio-Rad Laboratories, Inc Women Health Diagnostics Introduction
11.3.4 Bio-Rad Laboratories, Inc Revenue in Women Health Diagnostics Business (2019-2024)
11.3.5 Bio-Rad Laboratories, Inc Recent Development
11.4 Illumina, Inc
11.4.1 Illumina, Inc Company Detail
11.4.2 Illumina, Inc Business Overview
11.4.3 Illumina, Inc Women Health Diagnostics Introduction
11.4.4 Illumina, Inc Revenue in Women Health Diagnostics Business (2019-2024)
11.4.5 Illumina, Inc Recent Development
11.5 Laboratory Corporation of America Holdings
11.5.1 Laboratory Corporation of America Holdings Company Detail
11.5.2 Laboratory Corporation of America Holdings Business Overview
11.5.3 Laboratory Corporation of America Holdings Women Health Diagnostics Introduction
11.5.4 Laboratory Corporation of America Holdings Revenue in Women Health Diagnostics Business (2019-2024)
11.5.5 Laboratory Corporation of America Holdings Recent Development
11.6 Natera, Inc
11.6.1 Natera, Inc Company Detail
11.6.2 Natera, Inc Business Overview
11.6.3 Natera, Inc Women Health Diagnostics Introduction
11.6.4 Natera, Inc Revenue in Women Health Diagnostics Business (2019-2024)
11.6.5 Natera, Inc Recent Development
11.7 PerkinElmer, Inc
11.7.1 PerkinElmer, Inc Company Detail
11.7.2 PerkinElmer, Inc Business Overview
11.7.3 PerkinElmer, Inc Women Health Diagnostics Introduction
11.7.4 PerkinElmer, Inc Revenue in Women Health Diagnostics Business (2019-2024)
11.7.5 PerkinElmer, Inc Recent Development
11.8 Sequenom, Inc
11.8.1 Sequenom, Inc Company Detail
11.8.2 Sequenom, Inc Business Overview
11.8.3 Sequenom, Inc Women Health Diagnostics Introduction
11.8.4 Sequenom, Inc Revenue in Women Health Diagnostics Business (2019-2024)
11.8.5 Sequenom, Inc Recent Development
11.9 LifeCodexx
11.9.1 LifeCodexx Company Detail
11.9.2 LifeCodexx Business Overview
11.9.3 LifeCodexx Women Health Diagnostics Introduction
11.9.4 LifeCodexx Revenue in Women Health Diagnostics Business (2019-2024)
11.9.5 LifeCodexx Recent Development
11.10 Cenata
11.10.1 Cenata Company Detail
11.10.2 Cenata Business Overview
11.10.3 Cenata Women Health Diagnostics Introduction
11.10.4 Cenata Revenue in Women Health Diagnostics Business (2019-2024)
11.10.5 Cenata Recent Development
11.11 Berrygenomics
11.11.1 Berrygenomics Company Detail
11.11.2 Berrygenomics Business Overview
11.11.3 Berrygenomics Women Health Diagnostics Introduction
11.11.4 Berrygenomics Revenue in Women Health Diagnostics Business (2019-2024)
11.11.5 Berrygenomics Recent Development
11.12 BGI
11.12.1 BGI Company Detail
11.12.2 BGI Business Overview
11.12.3 BGI Women Health Diagnostics Introduction
11.12.4 BGI Revenue in Women Health Diagnostics Business (2019-2024)
11.12.5 BGI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
